Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models
- 1 January 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (1) , 415-422
Abstract
Lactating breast tissue and some breast cancers express the sodium/iodide symporter (NIS) and concentrate iodide. We recently demonstrated that all-trans retinoic acid (tRA) induces both NIS gene expression and iodide accumulation in vitro in well-differentiated human breast cancer cells (MCF-7). In the present study, we investigated the in vivo efficacy and specificity of tRA-stimulated iodide accumulation in mouse breast cancer models. Immunodeficient mice with MCF-7 xenograft tumors were treated with systemic tRA for 5 days. Iodide accumulation in the xenograft tumors was markedly increased, ∼15-fold greater than levels without treatment, and the effects were tRA dose dependent. Iodide accumulation in other organs was not significantly influenced by tRA treatment. Significant induction of NIS mRNA and protein in the xenograft tumors was observed after tRA treatment. Iodide accumulation and NIS mRNA expression were also selectively induced in breast cancer tissues in transgenic mice expressing the oncogene, polyoma virus middle T antigen. These data demonstrate selective induction of functional NIS in breast cancer by tRA. Treatment with short-term systemic retinoic acid, followed by radioiodide administration, is a potential tool in the diagnosis and treatment of some differentiated breast cancer.Keywords
This publication has 55 references indexed in Scilit:
- In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomasGene Therapy, 2002
- Identification and Characterization of a Putative Human Iodide Transporter Located at the Apical Membrane of ThyrocytesThe Journal of Clinical Endocrinology & Metabolism, 2002
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- Hormonal Regulation of Radioiodide Uptake Activity and Na+/I- Symporter Expression in Mammary GlandsThe Journal of Clinical Endocrinology & Metabolism, 2000
- Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.Journal of Clinical Investigation, 1998
- Increased Expression of the Na+/I- Symporter in Cultured Human Thyroid Cells Exposed to Thyrotropin and in Graves' Thyroid TissueThe Journal of Clinical Endocrinology & Metabolism, 1997
- Autoinduction of Retinoic Acid Metabolism to Polar Derivatives with Decreased Biological Activity in Retinoic Acid-sensitive, but Not in Retinoic Acid-resistant Human Breast Cancer CellsJournal of Biological Chemistry, 1997
- Regulation by Thyroid-Stimulating Hormone of Sodium/Iodide Symporter Gene Expression and Protein Levels in FRTL-5 CellsEndocrinology, 1997
- Retinoic Acid Down-regulation of Fibronectin and Retinoic Acid Receptor α Proteins in NIH-3T3 CellsJournal of Biological Chemistry, 1996
- Regulation of Retinoic Acid Receptor Expression in Dermal FibroblastsExperimental Cell Research, 1994